Cas no 885522-00-9 (7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole)

7-Chloro-3-iodo-1H-Indazole is a halogenated indazole derivative with significant utility in pharmaceutical and agrochemical research. Its distinct molecular structure, featuring chloro and iodo substituents, enhances its reactivity and versatility as a key intermediate in heterocyclic synthesis. The compound is particularly valuable in the development of biologically active molecules, including kinase inhibitors and antimicrobial agents. Its high purity and stability under standard conditions make it suitable for precise synthetic applications. Researchers favor this compound for its ability to facilitate selective functionalization, enabling the construction of complex scaffolds. Proper handling and storage are recommended to maintain its integrity for optimal performance in experimental workflows.
7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole structure
885522-00-9 structure
Product Name:7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole
CAS No:885522-00-9
MF:C7H4ClIN2
MW:278.47753238678
MDL:MFCD07781602
CID:840491
PubChem ID:24728215
Update Time:2025-06-12

7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole Chemical and Physical Properties

Names and Identifiers

    • 7-Chloro-3-iodo-1H-indazole
    • 7-?Chloro-?3-?iodo-1H-?Indazole
    • 7-Chloro-3-iodo (1H)indazole
    • 7-chloro-3-iodo-2H-indazole
    • 7-Chloro-3-iodo(1H)indazole
    • 1H-Indazole, 7-chloro-3-iodo-
    • FCH1324227
    • AB42709
    • AX8231441
    • V8643
    • ST24024502
    • 885522-00-9
    • AS-58989
    • EN300-3206328
    • 7-?Chloro-?3-?iodo-1H-?Indazole
    • SCHEMBL15866141
    • FT-0719816
    • CS-0190671
    • AKOS015850450
    • A861760
    • MFCD07781602
    • DTXSID70646272
    • A12918
    • DB-077989
    • 7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole
    • MDL: MFCD07781602
    • Inchi: 1S/C7H4ClIN2/c8-5-3-1-2-4-6(5)10-11-7(4)9/h1-3H,(H,10,11)
    • InChI Key: FTMZPQUNZZQFMX-UHFFFAOYSA-N
    • SMILES: IC1=C2C=CC=C(C2=NN1)Cl

Computed Properties

  • Exact Mass: 277.91100
  • Monoisotopic Mass: 277.91077g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 1
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 0
  • Complexity: 155
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 28.7
  • XLogP3: 2.9

Experimental Properties

  • PSA: 28.68000
  • LogP: 2.82090

7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
C906445-1g
7-CHLORO-3-IODO (1H)INDAZOLE
885522-00-9 98%
1g
2,067.30 2021-05-17
Fluorochem
216109-250mg
7-Chloro-3-iodo-1H-indazole
885522-00-9 95%
250mg
£188.00 2022-02-28
Fluorochem
216109-1g
7-Chloro-3-iodo-1H-indazole
885522-00-9 95%
1g
£438.00 2022-02-28
TRC
C368610-50mg
7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole
885522-00-9
50mg
$ 104.00 2023-04-18
TRC
C368610-100mg
7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole
885522-00-9
100mg
$ 184.00 2023-04-18
TRC
C368610-250mg
7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole
885522-00-9
250mg
$ 408.00 2023-04-18
TRC
C368610-500mg
7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole
885522-00-9
500mg
$ 787.00 2023-04-18
Alichem
A269002443-1g
7-Chloro-3-iodo-1H-indazole
885522-00-9 95%
1g
$356.31 2023-08-31
Chemenu
CM124274-1g
7-chloro-3-iodo-1H-indazole
885522-00-9 95%
1g
$311 2021-08-05
eNovation Chemicals LLC
Y0997359-5g
7-Chloro-3-iodo (1H)indazole
885522-00-9 95%
5g
$1000 2024-08-02

Additional information on 7-\u200bChloro-\u200b3-\u200biodo-1H-\u200bIndazole

Professional Introduction to Compound with CAS No. 885522-00-9 and Product Name: 7-Chloro-3-iodo-1H-indazole

The compound identified by the CAS number 885522-00-9 and the product name 7-Chloro-3-iodo-1H-indazole represents a significant molecule in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic aromatic compound, featuring a nitrogen-containing indazole core substituted with chloro and iodo groups, has garnered considerable attention due to its structural versatility and potential biological activities. The strategic placement of halogen atoms at the 7th and 3rd positions of the indazole ring enhances its reactivity, making it a valuable scaffold for the development of novel therapeutic agents.

In recent years, indazole derivatives have been extensively studied for their pharmacological properties, particularly in the context of anticancer, antimicrobial, and anti-inflammatory applications. The 7-Chloro-3-iodo-1H-indazole molecule, with its distinct halogenation pattern, exhibits unique chemical and biological characteristics that make it an attractive candidate for further exploration. The chloro group at the 7-position can participate in various chemical transformations, including cross-coupling reactions, while the iodo group at the 3-position serves as a versatile handle for further functionalization. These features enable chemists to modify the molecule in multiple ways, allowing for the synthesis of a diverse array of derivatives with tailored biological activities.

One of the most compelling aspects of 7-Chloro-3-iodo-1H-indazole is its potential as a precursor in the synthesis of more complex pharmacophores. The indazole core is a well-documented scaffold in drug discovery, with several approved drugs featuring this motif. By leveraging the reactivity of the halogen substituents, researchers can introduce additional functional groups or linkages, thereby expanding the pharmacological spectrum of the compound. For instance, palladium-catalyzed cross-coupling reactions can be employed to attach aryl or heteroaryl groups to the indazole ring, generating novel derivatives with enhanced binding affinity to biological targets.

Recent studies have highlighted the importance of halogenated indazole derivatives in medicinal chemistry. A notable example is their application in targeted therapy for cancer. The halogen atoms in 7-Chloro-3-iodo-1H-indazole facilitate its incorporation into kinase inhibitors and other small-molecule drugs designed to disrupt cancer cell signaling pathways. The ability to precisely tune the electronic properties of the indazole ring through halogenation allows for selective interactions with specific proteins involved in tumor growth and progression. This has led to several promising candidates entering preclinical development pipelines.

The synthesis of 7-Chloro-3-iodo-1H-indazole involves multi-step organic transformations that highlight modern synthetic methodologies. Traditional approaches often rely on cyclization reactions followed by halogenation steps to construct the indazole core. However, advances in catalytic systems have enabled more efficient routes to these compounds. For example, transition metal-catalyzed cyclizations can provide access to indazole derivatives in higher yields and with fewer byproducts compared to classical methods. Additionally, modern techniques such as flow chemistry have been employed to optimize reaction conditions and improve scalability.

The biological evaluation of 7-Chloro-3-iodo-1H-indazole has revealed several intriguing properties. In vitro assays have demonstrated its activity against various disease-relevant targets, including kinases and transcription factors. Notably, derivatives derived from this scaffold have shown promising results in inhibiting aberrant signaling pathways associated with chronic diseases such as cancer and inflammation. The presence of both chloro and iodo substituents allows for further derivatization to fine-tune potency and selectivity, making it a versatile tool for drug discovery.

The impact of computational chemistry on the study of 7-Chloro-3-iodo-1H-indazole cannot be overstated. Molecular modeling techniques have been instrumental in understanding how structural modifications influence biological activity. By predicting binding modes and interaction energies between the compound and its targets, researchers can rationalize experimental observations and guide synthetic efforts toward more effective drug candidates. Furthermore, virtual screening methods enable high-throughput evaluation of large libraries of derivatives, accelerating the discovery process.

In conclusion,7-Chloro-3-iodo-1H-indazole (CAS No. 885522-00-9) represents a compelling molecule with significant potential in pharmaceutical research. Its unique structural features—particularly the halogenation pattern—make it a valuable scaffold for developing novel therapeutic agents targeting various diseases. Advances in synthetic chemistry, coupled with modern computational methods, continue to enhance our ability to explore its full pharmacological potential. As research progresses,7-Chloro-3-iodo-1H-indazole is poised to play an important role in future drug development efforts.

Recommended suppliers
Beyond Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.